EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network

Sonia Vázquez-Morón iD, María Iglesias-Caballero, José Antonio Lepe, Federico Garcia iD, Santiago Melón iD, José M Marimon iD, Darío García de Viedma, Maria Dolores Folgueira iD, Juan Carlos Galán iD, Carla López-Causapé, Rafael Benito-Ruesca iD, Julia Alcoba-Florez und 11 weitere

International Journal of Molecular Sciences · 10.05.2023 · 24 (10) · 8573

DOI: 10.3390/ijms24108573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.05.2023. Verfasst von Sonia Vázquez-Morón und 22 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Viruses and Influenza Unit, National Centre for Microbiology, Instituto de Salud Carlos III, 28222 Majadahonda, Spain. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Centre for Disease Prevention and Control, Instituto de Salud Carlos III, UNESPA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Millions of SARS-CoV-2 whole genome sequences have been generated to date. However, good quality data and adequate surveillance systems are required to contribute to meaningful surveillance in public health. In this context, the network of Spanish laboratories for coronavirus (RELECOV) was created with the main goal of promoting actions to speed up the detection, analyses, and evaluation of SARS-CoV-2 at a national level, partially structured and financed by an ECDC-HERA-Incubator action (ECDC/GRANT/2021/024). A SARS-CoV-2 sequencing quality control assessment (QCA) was developed to evaluate the network’s technical capacity. QCA full panel results showed a lower hit rate for lineage assignment compared to that obtained for variants. Genomic data comprising 48,578 viral genomes were studied and evaluated to monitor SARS-CoV-2. The developed network actions showed a 36% increase in sharing viral sequences. In addition, analysis of lineage/sublineage-defining mutations to track the virus showed characteristic mutation profiles for the Delta and Omicron variants. Further, phylogenetic analyses strongly correlated with different variant clusters, obtaining a robust reference tree. The RELECOV network has made it possible to improve and enhance the genomic surveillance of SARS-CoV-2 in Spain. It has provided and evaluated genomic tools for viral genome monitoring and characterization that make it possible to increase knowledge efficiently and quickly, promoting the genomic surveillance of SARS-CoV-2 in Spain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansSpainPhylogenyGenomicsMutation

Stichwörter der Autor:innen

SARS-CoV-2VOCsgenomic surveillance Spainlaboratory network RELECOVlineagesmutationnational QCAphylogeny

Autor:innen und Institutionen

  • Respiratory Viruses and Influenza Unit, National Centre for Microbiology, Instituto de Salud Carlos III, 28222 Majadahonda, Spain.
  • CIBER de Epidemiología y Salud Pública (CIBERESP), ISCIII, 28029 Madrid, Spain.
  • Microbiology Service, Hospital Universitario Virgen del Rocio, 41013 Sevilla, Spain.
  • Microbiology Service, Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria Ibs. Granada, 18016 Granada, Spain.
  • CIBER de Enfermedades Infecciosas (CIBERINFEC), ISCIII, 28029 Madrid, Spain.
  • Microbiology Service, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.

ORCID-Profile: Sonia Vázquez-Morón, Federico Garcia, Santiago Melón, José M Marimon, Maria Dolores Folgueira, Juan Carlos Galán, Rafael Benito-Ruesca, Fernando Gonzalez Candelas, María de Toro, Sonia Pérez Castro, Angel Zaballos, Francisco Pozo, Inmaculada Casas

Förderung

  • European Centre for Disease Prevention and Control
  • Instituto de Salud Carlos III
  • UNESPA
  • Fundación Canaria Instituto de Investigación Sanitaria de Canarias
  • Cabildo Insular de Tenerife
  • ECDC
  • Fondo COVID
  • COVIDSEQ-UNESPA

Zitieren

APA

Vázquez-Morón, S., Iglesias-Caballero, M., Lepe, J. A., Garcia, F., Melón, S., Marimon, J. M., García de Viedma, D., Folgueira, M. D., Galán, J. C., López-Causapé, C., Benito-Ruesca, R., Alcoba-Florez, J., Gonzalez Candelas, F., Toro, M., Fajardo, M., Ezpeleta, C., Lázaro, F., Pérez Castro, S., Cuesta, I., …, & On Behalf Of Relecov Network Members (2023). Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network. International Journal of Molecular Sciences, 24(10), 8573. https://doi.org/10.3390/ijms24108573

Vancouver

Vázquez-Morón S, Iglesias-Caballero M, Lepe JA, Garcia F, Melón S, Marimon JM, et al. Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network. International Journal of Molecular Sciences. 2023;24(10):8573. doi:10.3390/ijms24108573

BibTeX
@article{VzquezMorn2023,
  author = {Vázquez-Morón, Sonia and Iglesias-Caballero, María and Lepe, José Antonio and Garcia, Federico and Melón, Santiago and Marimon, José M and García de Viedma, Darío and Folgueira, Maria Dolores and Galán, Juan Carlos and López-Causapé, Carla and Benito-Ruesca, Rafael and Alcoba-Florez, Julia and Gonzalez Candelas, Fernando and Toro, María de and Fajardo, Miguel and Ezpeleta, Carmen and Lázaro, Fernando and Pérez Castro, Sonia and Cuesta, Isabel and Zaballos, Angel and Pozo, Francisco and Casas, Inmaculada and On Behalf Of Relecov Network Members},
  title = {Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {10},
  pages = {8573},
  doi = {10.3390/ijms24108573}
}
Kostenlos starten →